Pharma

Biotech Brittany Trang

STAT Plus: ‘Sarepta’s like a curse on me’: FDA commissioner dismisses controversy over Elevidys

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about a Novo weight loss study, a GSK vaccine failure, and more

The Readout Meghana Keshavan

STAT Plus: Eli Lilly releases new data on weekly insulin

The Readout Meghana Keshavan

STAT Plus: Five biotech news stories you need to read today

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about a Roivant deal, limited access to medicines and more

Pharmalot Ed Silverman

STAT Plus: Pharma is still struggling to widen access to medicines — and reach patients — in low- and middle-income countries

Video Anna Yeo

STAT Plus: The little-known bill that made drugs more affordable

Pharma Elisabeth Rosenthal — KFF Health News

STAT Plus: With TV drug ads, what you see is not necessarily what you get

The Readout Meghana Keshavan

STAT Plus: Terns’ GLP-1 pill leads to weight loss in early study

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about a Maryland law governing 340B discounts, an obesity drug, and more

Biotech Matthew Herper

STAT Plus: With a win in lung cancer, biotech’s wealthiest outsider surfs to new heights

Pharmalot Ed Silverman

STAT Plus: Up and down the ladder: The latest comings and goings

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about FDA inspections, Lilly insulin trial results, and more

Pharma Jason Mast

STAT Plus: U.K. charities give $36 million to start new drugs for childhood tumors 

Pharma Matthew Perrone and Nicky Forster — Associated Press

STAT Plus: Nearly 2,000 drug manufacturing plants are overdue for FDA inspections after Covid delays

The Readout Meghana Keshavan

STAT Plus: Lilly has more positive data on its weekly insulin

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about China detaining AstraZeneca staff, pharma layoffs, and more

Health Elaine Chen and Allison DeAngelis

STAT Plus: Can amylin drugs best Wegovy and Zepbound? Companies bet on next big obesity target

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about a Vaxcyte vaccine, Ozempic shortages, and more

The Readout Elaine Chen

STAT Plus: BioMarin’s big day today

Pharmalot Ed Silverman

STAT Plus: Greece’s antitrust regulator probes Novartis over practices tied to a pricey eye drug

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about Medicare drug prices, a Sanofi MS pill, and more

The Readout Meghana Keshavan

STAT Plus: The biotech news you need to read this morning

Pharma Andrew Joseph

STAT Plus: At major cardiology conference, Wegovy’s the word

Biotech Matthew Herper

STAT Plus: Sanofi says its new pill for multiple sclerosis succeeded in a key trial, boosting its research ambitions

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about Wegovy study results, an Alnylam heart drug, and more

Pharma Brittany Trang

STAT Plus: Switching asthma inhalers could reduce carbon emissions, says study

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about Zepbound pricing caveats, PBM congressional testimony, and more

The Readout Meghana Keshavan

STAT Plus: Genentech is shedding even more employees